Literature DB >> 2017010

Exercise and the incidence of upper respiratory tract infections.

G W Heath1, E S Ford, T E Craven, C A Macera, K L Jackson, R R Pate.   

Abstract

We examined illness patterns in a cohort of 530 male and female runners who completed a monthly log for 12 months. The average number of upper respiratory tract infections (URTIs) per person per year for the cohort was 1.2. An upper respiratory tract infection was indicated by the report of any of the following symptoms; runny nose, sore throat, or cough. Using a multiple logistic regression model, the following factors were found to be associated with having one or more URTIs in the follow-up period: living alone (odds ratio = 2.27, 95% CI = 1.01, 5.09), running mileage (486-865 miles, odds ratio = 2.00, 95% CI = 1.01, 2.78; 866-1388 miles, odds ratio = 3.50, 95% CI = 1.52, 4.44; greater than 1388 miles, odds ratio = 2.96, 95% CI = 1.30, 3.68), body mass index greater than the 75th percentile (odds ratio = 0.58, 95% CI = 0.35, 0.94), and male gender (odds ratio = 0.14, 95% CI = 0.03, 0.68). A significant interaction was found to exist between gender and alcohol use, with the association between alcohol use and upper respiratory tract infections being positive in males and negative in females. These results suggest that running dosage (mileage) is a significant risk factor for upper respiratory tract infections in this group of exercisers.

Entities:  

Mesh:

Year:  1991        PMID: 2017010

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  35 in total

1.  Change in perforin-positive peripheral blood lymphocyte (PBL) subpopulations following exercise.

Authors:  R Staats; S Balkow; S Sorichter; H Northoff; H Matthys; W Luttmann; A Berg; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  The effect of maximal exercise on the activity of neutrophil granulocytes in highly trained athletes in a moderate training period.

Authors:  V Hack; G Strobel; J P Rau; H Weicker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

3.  Salivary extracellular heat shock protein 70 (eHSP70) levels increase after 59 min of intense exercise and correlate with resting salivary secretory immunoglobulin A (SIgA) levels at rest.

Authors:  Yosuke Murase; Kazuhiro Shimizu; Yuko Tanimura; Yukichi Hanaoka; Koichi Watanabe; Ichiro Kono; Shumpei Miyakawa
Journal:  Cell Stress Chaperones       Date:  2015-11-25       Impact factor: 3.667

4.  Risk of upper respiratory tract infection in athletes: an epidemiologic and immunologic perspective.

Authors:  D C Nieman
Journal:  J Athl Train       Date:  1997-10       Impact factor: 2.860

5.  The immune system and serum glutamine during a triathlon.

Authors:  T Rohde; D A MacLean; A Hartkopp; B K Pedersen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

6.  Changes in natural killer cell subpopulations over a winter training season in elite swimmers.

Authors:  Luís Rama; Ana Maria Teixeira; Alice Matos; Grasiely Borges; Ana Henriques; Michael Gleeson; Susana Pedreiro; Edith Filaire; Francisco Alves; Artur Paiva
Journal:  Eur J Appl Physiol       Date:  2012-09-19       Impact factor: 3.078

7.  The effect on immunity of long-term intensive training in elite swimmers.

Authors:  M Gleeson; W A McDonald; A W Cripps; D B Pyne; R L Clancy; P A Fricker
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 8.  Alcohol and sport. Impact of social drinking on recreational and competitive sports performance.

Authors:  C P O'Brien
Journal:  Sports Med       Date:  1993-02       Impact factor: 11.136

9.  Exercise and respiratory tract viral infections.

Authors:  Stephen A Martin; Brandt D Pence; Jeffrey A Woods
Journal:  Exerc Sport Sci Rev       Date:  2009-10       Impact factor: 6.230

10.  Decreased salivary immunoglobulin A secretion rate after intense interval exercise in elite kayakers.

Authors:  L T Mackinnon; E Ginn; G J Seymour
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.